Congestive Heart Failure (Heart Failure) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update

Powered by

All the vital news, analysis, and commentary curated by our industry experts.

$2500

Congestive heart failure (heart failure) report provides comprehensive information on the therapeutics under development for Congestive Heart Failure (Heart Failure), complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases. Additionally, the report provides an overview of key players involved in therapeutic development for Congestive Heart Failure (Heart Failure) and features dormant and discontinued projects.

Key Targets in the Heart Failure Pipeline Market

The key targets in the heart failure pipeline market are Atrial Natriuretic Peptide Receptor 1, Beta 1 Adrenergic Receptor, Sodium/Glucose Cotransporter 2, Mineralocorticoid Receptor, Beta 2 Adrenergic Receptor, Myosin, and Beta 3 Adrenergic Receptor. Atrial Natriuretic Peptide Receptor 1 has the highest pipeline products.

Heart Failure Pipeline Market, by Targets

Heart Failure Pipeline Market, by Targets

For more target insights, download a free report sample

Key MoA in the Heart Failure Pipeline Market

The key MoA in the heart failure pipeline market are Atrial Natriuretic Peptide Receptor 1 Agonist, Sodium/Glucose Cotransporter 2 Inhibitor, Mineralocorticoid Receptor Antagonist, Beta 1 Adrenergic Receptor Antagonist, Beta 2 Adrenergic Receptor Antagonist, Beta 3 Adrenergic Receptor Antagonist, and Myosin Activator. Atrial Natriuretic Peptide Receptor 1 Agonist have the highest number of pipeline products.

Heart Failure Pipeline Market, by MoA

Heart Failure Pipeline Market, by MoA

For more MoA insights, download a free report sample

Key RoA in the Heart Failure Pipeline Market

The key RoA in the heart failure pipeline market are oral, intravenous, subcutaneous, parenteral, intracardiac, intracoronary, and intravenous drip. Oral has the highest number of pipeline products.

Heart Failure Pipeline Market, by RoA

Heart Failure Pipeline Market, by RoA

For more RoA insights, download a free report sample

Key Molecule Types in the Heart Failure Pipeline Market

The key molecule types in the heart failure pipeline market are small molecule, cell therapy, gene therapy, synthetic peptide, oligonucleotide, fusion protein, and monoclonal antibody. Small molecule has the highest number of pipeline products in the heart failure pipeline market.

Heart Failure Pipeline Market, by Molecule Types

Heart Failure Pipeline Market, by Molecule Types

For more molecule type insights, download a free report sample

Key Companies in the Heart Failure Pipeline Market

The key companies in the heart failure pipeline market are AstraZeneca Plc, Bristol-Myers Squibb Co, Bayer AG, Renova Therapeutics Inc, Celixir Ltd, Cytokinetics Inc, Saillant Therapeutics BV, and Sarfez Pharmaceuticals Inc. AstraZeneca Plc has the highest number of pipeline products.

Heart Failure Pipeline Market, by Companies

Heart Failure Pipeline Market, by Companies

To know about more companies, download a free report sample

Market report overview

Key targets Atrial Natriuretic Peptide Receptor 1, Beta 1 Adrenergic Receptor, Sodium/Glucose Cotransporter 2, Mineralocorticoid Receptor, Beta 2 Adrenergic Receptor, Myosin, and Beta 3 Adrenergic Receptor
Key MoA Atrial Natriuretic Peptide Receptor 1 Agonist, Sodium/Glucose Cotransporter 2 Inhibitor, Mineralocorticoid Receptor Antagonist, Beta 1 Adrenergic Receptor Antagonist, Beta 2 Adrenergic Receptor Antagonist, Beta 3 Adrenergic Receptor Antagonist, and Myosin Activator
Key RoA Oral, Intravenous, Subcutaneous, Parenteral, Intracardiac, Intracoronary, and Intravenous Drip
Key molecule types Small Molecule, Cell Therapy, Gene Therapy, Synthetic Peptide, Oligonucleotide, Fusion Protein, and Monoclonal Antibody
Key companies AstraZeneca Plc, Bristol-Myers Squibb Co, Bayer AG, Renova Therapeutics Inc, Celixir Ltd, Cytokinetics Inc, Saillant Therapeutics BV, and Sarfez Pharmaceuticals Inc

Scope

  • The pipeline guide provides a snapshot of the global therapeutic landscape of Congestive Heart Failure (Cardiovascular).
  • The pipeline guide reviews pipeline therapeutics for Congestive Heart Failure (Cardiovascular) by companies and universities/research institutes based on information derived from company and industry-specific sources.
  • The pipeline guide covers pipeline products based on several stages of development ranging from pre-registration till discovery and undisclosed stages.
  • The pipeline guide features descriptive drug profiles for the pipeline products which comprise, product description, descriptive licensing and collaboration details, R&D brief, MoA & other developmental activities.
  • The pipeline guide reviews key companies involved in Congestive Heart Failure (Cardiovascular) therapeutics and enlists all their major and minor projects.
  • The pipeline guide evaluates Congestive Heart Failure (Cardiovascular) therapeutics based on mechanism of action (MoA), drug target, route of administration (RoA) and molecule type.
  • The pipeline guide encapsulates all the dormant and discontinued pipeline projects.
  • The pipeline guide reviews latest news related to pipeline therapeutics for Congestive Heart Failure (Cardiovascular)

Reasons to Buy

  • Procure strategically important competitor information, analysis, and insights to formulate effective R&D strategies.
  • Recognize emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage.
  • Find and recognize significant and varied types of therapeutics under development for Congestive Heart Failure (Cardiovascular).
  • Classify potential new clients or partners in the target demographic.
  • Develop tactical initiatives by understanding the focus areas of leading companies.
  • Plan mergers and acquisitions meritoriously by identifying key players and it’s most promising pipeline therapeutics.
  • Formulate corrective measures for pipeline projects by understanding Congestive Heart Failure (Cardiovascular) pipeline depth and focus of Indication therapeutics.
  • Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope.
  • Adjust the therapeutic portfolio by recognizing discontinued projects and understand from the know-how what drove them from pipeline.

4TEEN4 Pharmaceuticals GmbH
Adicet Bio Inc
Adrenomed AG
AgeX Therapeutics Inc
Akebia Therapeutics Inc
Allysta Pharmaceuticals Inc
AnaCardio AB
Anchored Rsk3 Inhibitors LLC
Angion Biomedica Corp
Animatus Biosciences LLC
Antlia Bioscience Inc
APIE Therapeutics Inc
Araim Pharmaceuticals Inc
ARCA biopharma Inc
ARMGO Pharma Inc
Ascendia Pharmaceuticals Inc
Astellas Pharma Inc
AstraZeneca Plc
Athersys Inc
Avery Therapeutics Inc
Bayer AG
Betagenon AB
BioCardia Inc
Biopeutics Co Ltd
BlueRock Therapeutics LLC
Boehringer Ingelheim International GmbH
Boryung Pharmaceutical Co Ltd
Bristol-Myers Squibb Co
C&C BioPharma LLC
Capricor Therapeutics Inc
Cardiac RSK3 Inhibitors LLC
Cardiol Therapeutics Inc
Cardior Pharmaceuticals GmbH
CCRP Therapeutics GmbH
Celixir Ltd
Cell Tech Pharmed Co
Cellvation Inc
Chong Kun Dang Holdings Corp
Chong Kun Dang Pharmaceutical Corp
Corteria Pharmaceuticals SAS
Creative Medical Technology Holdings Inc
CuronBiotech Inc
Cytokinetics Inc
Daiichi Sankyo Co Ltd
DiNAQOR AG
Dynomics Inc
Eli Lilly and Co
Elyson Pharmaceutical Co Ltd
Ethicare GmbH
Evotec SE
Exscien Corp
F. Hoffmann-La Roche Ltd
G3 Pharmaceuticals Inc
GB Sciences Inc
Genome Biologics UG
GlaxoSmithKline Plc
Guangdong East Sunshine Pharmaceutical Co Ltd
Heartseed Inc
Help Therapeutics
Hemostemix Inc
Hunan Jingfeng Pharmaceutical Co Ltd
Huons Co Ltd
Hyloris Pharmaceuticals SA
I-Cordis LLC
iHeart Japan Corp
Imara Inc
Imbria Pharmaceuticals Inc
Immunwork Inc
Innolife Co Ltd
Innopharmax Inc
Inserm Transfert SA
Intra-Cellular Therapies Inc
INVENT Pharmaceuticals Inc
Ionis Pharmaceuticals Inc
Japan Tobacco Inc
Johnson & Johnson
Katakura Industries Co Ltd
KBP Biosciences Co Ltd
Larix Bioscience LLC
Lead Discovery Center GmbH
Les Laboratoires Servier SAS
Lexicon Pharmaceuticals Inc
Madeleine Pharmaceuticals Inc
Mesoblast Ltd
Metcela Inc
Mitsubishi Tanabe Pharma Corp
Moderna Inc
NanoCor Therapeutics Inc
NeoProgen Inc
Novartis AG
Novelstar Pharmaceuticals Inc
NovoMedix LLC
Olatec Therapeutics LLC
Organicell Regenerative Medicine Inc
Orig3N Inc
Orion Corp
Orizuru Therapeutics Inc
Otsuka Pharmaceutical Co Ltd
Palatin Technologies Inc
Paradigm Biopharmaceuticals Ltd
Pfizer Inc
Pharchoice Therapeutics Inc
PhaseBio Pharmaceuticals Inc
Phrixus Pharmaceuticals Inc
Poxel SA
Procella Therapeutics AB
Prolifagen LLC
Proveca Ltd
Q BioMed Inc
Qanatpharma GmbH
Quantum Genomics SA
Qurgen Inc
Ramino-Bio Ltd
Recardio Inc
Regeneron Pharmaceuticals Inc
Renova Therapeutics Inc
Ribomic Inc
Rivus Pharmaceuticals Inc
Rnatives Ltd
Rockwell Medical Inc
Saillant Therapeutics BV
Saje Pharma LLC
Saliogen Therapeutics Inc
Salubris Biotherapeutics Inc
Sana Biotechnology Inc
Sanofi
Sarfez Pharmaceuticals Inc
scPharmaceuticals Inc
Senju Pharmaceutical Co Ltd
Shandong Danhong Pharmaceutical Co Ltd
Shanghai Hongyitang Biomedical Technology Co Ltd
Shanghai Life Science & Technology
Shenzhen Salubris Pharmaceuticals Co Ltd
Shin Poong Pharm Co Ltd
Signal Pharma Ltd
Silver Creek Pharmaceuticals Inc
siRNAgen Therapeutics Corp
Sorrento Therapeutics Inc
Stemedica Cell Technologies Inc
Sumocor LLC
Sun Pharma Advanced Research Company Ltd
Suzhou Pharmavan Cancer Research Center Co Ltd
T&R Biofab Co Ltd
Takeda Pharmaceutical Co Ltd
Techfields Pharma Co Ltd
Tenaya Therapeutics Inc
Titan Pharmaceuticals Inc
Toa Eiyo Ltd
Torrent Pharmaceuticals Ltd
TransThera Sciences (Nanjing) Inc
TreeFrog Therapeutics SAS
Trio Medicines Ltd
Triple-Gene LLC
U.S. Stem Cell Inc
Valo Health LLC
Viatris Inc
ViCardia Therapeutics Inc
Viera BioScience Inc
Vifor Pharma Ltd
Viridian Therapeutics Inc
Viscofan BioEngineering
Windtree Therapeutics Inc
Wuhan LL Science and Technology Development Co Ltd
XyloCor Therapeutics Inc
YAP Therapeutics Inc
Zensun (Shanghai) Sci & Tech Co Ltd

Table of Contents

Table of Contents

List of Tables

List of Figures

Introduction

Global Markets Direct Report Coverage

Congestive Heart Failure (Heart Failure) – Overview

Congestive Heart Failure (Heart Failure) – Therapeutics Development

Pipeline Overview

Pipeline by Companies

Pipeline by Universities/Institutes

Products under Development by Companies

Products under Development by Universities/Institutes

Congestive Heart Failure (Heart Failure) – Therapeutics Assessment

Assessment by Target

Assessment by Mechanism of Action

Assessment by Route of Administration

Assessment by Molecule Type

Congestive Heart Failure (Heart Failure) – Companies Involved in Therapeutics Development

Congestive Heart Failure (Heart Failure) – Drug Profiles

Congestive Heart Failure (Heart Failure) – Dormant Projects

Congestive Heart Failure (Heart Failure) – Discontinued Products

Congestive Heart Failure (Heart Failure) – Product Development Milestones

Featured News & Press Releases

Appendix

Methodology

Coverage

Secondary Research

Primary Research

Expert Panel Validation

Contact Us

Disclaimer

Table

List of Tables

Number of Products under Development for Congestive Heart Failure (Heart Failure), 2022

Number of Products under Development by Companies, 2022

Number of Products under Development by Companies, 2022 (Contd..1)

Number of Products under Development by Companies, 2022 (Contd..2)

Number of Products under Development by Companies, 2022 (Contd..3)

Number of Products under Development by Companies, 2022 (Contd..4)

Number of Products under Development by Companies, 2022 (Contd..5)

Number of Products under Development by Companies, 2022 (Contd..6)

Number of Products under Development by Companies, 2022 (Contd..7)

Number of Products under Development by Companies, 2022 (Contd..8)

Number of Products under Development by Universities/Institutes, 2022

Products under Development by Companies, 2022

Products under Development by Companies, 2022 (Contd..1)

Products under Development by Companies, 2022 (Contd..2)

Products under Development by Companies, 2022 (Contd..3)

Products under Development by Companies, 2022 (Contd..4)

Products under Development by Companies, 2022 (Contd..5)

Products under Development by Companies, 2022 (Contd..6)

Products under Development by Companies, 2022 (Contd..7)

Products under Development by Companies, 2022 (Contd..8)

Products under Development by Companies, 2022 (Contd..9)

Products under Development by Companies, 2022 (Contd..10)

Products under Development by Companies, 2022 (Contd..11)

Products under Development by Companies, 2022 (Contd..12)

Products under Development by Companies, 2022 (Contd..13)

Products under Development by Companies, 2022 (Contd..14)

Products under Development by Universities/Institutes, 2022

Products under Development by Universities/Institutes, 2022 (Contd..1)

Number of Products by Stage and Target, 2022

Number of Products by Stage and Target, 2022 (Contd..1)

Number of Products by Stage and Target, 2022 (Contd..2)

Number of Products by Stage and Target, 2022 (Contd..3)

Number of Products by Stage and Target, 2022 (Contd..4)

Number of Products by Stage and Mechanism of Action, 2022

Number of Products by Stage and Mechanism of Action, 2022 (Contd..1)

Number of Products by Stage and Mechanism of Action, 2022 (Contd..2)

Number of Products by Stage and Mechanism of Action, 2022 (Contd..3)

Number of Products by Stage and Mechanism of Action, 2022 (Contd..4)

Number of Products by Stage and Route of Administration, 2022

Number of Products by Stage and Molecule Type, 2022

Congestive Heart Failure (Heart Failure) – Pipeline by 4TEEN4 Pharmaceuticals GmbH, 2022

Congestive Heart Failure (Heart Failure) – Pipeline by Adicet Bio Inc, 2022

Congestive Heart Failure (Heart Failure) – Pipeline by Adrenomed AG, 2022

Congestive Heart Failure (Heart Failure) – Pipeline by AgeX Therapeutics Inc, 2022

Congestive Heart Failure (Heart Failure) – Pipeline by Akebia Therapeutics Inc, 2022

Congestive Heart Failure (Heart Failure) – Pipeline by Allysta Pharmaceuticals Inc, 2022

Congestive Heart Failure (Heart Failure) – Pipeline by AnaCardio AB, 2022

Congestive Heart Failure (Heart Failure) – Pipeline by Anchored Rsk3 Inhibitors LLC, 2022

Congestive Heart Failure (Heart Failure) – Pipeline by Angion Biomedica Corp, 2022

Congestive Heart Failure (Heart Failure) – Pipeline by Animatus Biosciences LLC, 2022

Congestive Heart Failure (Heart Failure) – Pipeline by Antlia Bioscience Inc, 2022

Congestive Heart Failure (Heart Failure) – Pipeline by APIE Therapeutics Inc, 2022

Congestive Heart Failure (Heart Failure) – Pipeline by Araim Pharmaceuticals Inc, 2022

Congestive Heart Failure (Heart Failure) – Pipeline by ARCA biopharma Inc, 2022

Congestive Heart Failure (Heart Failure) – Pipeline by ARMGO Pharma Inc, 2022

Congestive Heart Failure (Heart Failure) – Pipeline by Ascendia Pharmaceuticals Inc, 2022

Congestive Heart Failure (Heart Failure) – Pipeline by Astellas Pharma Inc, 2022

Congestive Heart Failure (Heart Failure) – Pipeline by AstraZeneca Plc, 2022

Congestive Heart Failure (Heart Failure) – Pipeline by Athersys Inc, 2022

Congestive Heart Failure (Heart Failure) – Pipeline by Avery Therapeutics Inc, 2022

Congestive Heart Failure (Heart Failure) – Pipeline by Bayer AG, 2022

Congestive Heart Failure (Heart Failure) – Pipeline by Betagenon AB, 2022

Congestive Heart Failure (Heart Failure) – Pipeline by BioCardia Inc, 2022

Congestive Heart Failure (Heart Failure) – Pipeline by Biopeutics Co Ltd, 2022

Congestive Heart Failure (Heart Failure) – Pipeline by BlueRock Therapeutics LLC, 2022

Congestive Heart Failure (Heart Failure) – Pipeline by Boehringer Ingelheim International GmbH, 2022

Congestive Heart Failure (Heart Failure) – Pipeline by Boryung Pharmaceutical Co Ltd, 2022

Congestive Heart Failure (Heart Failure) – Pipeline by Bristol-Myers Squibb Co, 2022

Congestive Heart Failure (Heart Failure) – Pipeline by C&C BioPharma LLC, 2022

Congestive Heart Failure (Heart Failure) – Pipeline by Capricor Therapeutics Inc, 2022

Congestive Heart Failure (Heart Failure) – Pipeline by Cardiac RSK3 Inhibitors LLC, 2022

Congestive Heart Failure (Heart Failure) – Pipeline by Cardiol Therapeutics Inc, 2022

Congestive Heart Failure (Heart Failure) – Pipeline by Cardior Pharmaceuticals GmbH, 2022

Congestive Heart Failure (Heart Failure) – Pipeline by CCRP Therapeutics GmbH, 2022

Congestive Heart Failure (Heart Failure) – Pipeline by Celixir Ltd, 2022

Congestive Heart Failure (Heart Failure) – Pipeline by Cell Tech Pharmed Co, 2022

Congestive Heart Failure (Heart Failure) – Pipeline by Cellvation Inc, 2022

Congestive Heart Failure (Heart Failure) – Pipeline by Chong Kun Dang Holdings Corp, 2022

Congestive Heart Failure (Heart Failure) – Pipeline by Chong Kun Dang Pharmaceutical Corp, 2022

Congestive Heart Failure (Heart Failure) – Pipeline by Corteria Pharmaceuticals SAS, 2022

Congestive Heart Failure (Heart Failure) – Pipeline by Creative Medical Technology Holdings Inc, 2022

Congestive Heart Failure (Heart Failure) – Pipeline by CuronBiotech Inc, 2022

Congestive Heart Failure (Heart Failure) – Pipeline by Cytokinetics Inc, 2022

Congestive Heart Failure (Heart Failure) – Pipeline by Daiichi Sankyo Co Ltd, 2022

Congestive Heart Failure (Heart Failure) – Pipeline by DiNAQOR AG, 2022

Congestive Heart Failure (Heart Failure) – Pipeline by Dynomics Inc, 2022

Congestive Heart Failure (Heart Failure) – Pipeline by Eli Lilly and Co, 2022

Congestive Heart Failure (Heart Failure) – Pipeline by Elyson Pharmaceutical Co Ltd, 2022

Congestive Heart Failure (Heart Failure) – Pipeline by Ethicare GmbH, 2022

Congestive Heart Failure (Heart Failure) – Pipeline by Evotec SE, 2022

Congestive Heart Failure (Heart Failure) – Pipeline by Exscien Corp, 2022

Congestive Heart Failure (Heart Failure) – Pipeline by F. Hoffmann-La Roche Ltd, 2022

Congestive Heart Failure (Heart Failure) – Pipeline by G3 Pharmaceuticals Inc, 2022

Congestive Heart Failure (Heart Failure) – Pipeline by GB Sciences Inc, 2022

Congestive Heart Failure (Heart Failure) – Pipeline by Genome Biologics UG, 2022

Congestive Heart Failure (Heart Failure) – Pipeline by GlaxoSmithKline Plc, 2022

Congestive Heart Failure (Heart Failure) – Pipeline by Guangdong East Sunshine Pharmaceutical Co Ltd, 2022

Congestive Heart Failure (Heart Failure) – Pipeline by Heartseed Inc, 2022

Congestive Heart Failure (Heart Failure) – Pipeline by Help Therapeutics, 2022

Congestive Heart Failure (Heart Failure) – Pipeline by Hemostemix Inc, 2022

Congestive Heart Failure (Heart Failure) – Pipeline by Hunan Jingfeng Pharmaceutical Co Ltd, 2022

Congestive Heart Failure (Heart Failure) – Pipeline by Huons Co Ltd, 2022

Congestive Heart Failure (Heart Failure) – Pipeline by Hyloris Pharmaceuticals SA, 2022

Congestive Heart Failure (Heart Failure) – Pipeline by I-Cordis LLC, 2022

Congestive Heart Failure (Heart Failure) – Pipeline by iHeart Japan Corp, 2022

Congestive Heart Failure (Heart Failure) – Pipeline by Imara Inc, 2022

Congestive Heart Failure (Heart Failure) – Pipeline by Imbria Pharmaceuticals Inc, 2022

Congestive Heart Failure (Heart Failure) – Pipeline by Immunwork Inc, 2022

Congestive Heart Failure (Heart Failure) – Pipeline by Innolife Co Ltd, 2022

Congestive Heart Failure (Heart Failure) – Pipeline by Innopharmax Inc, 2022

Congestive Heart Failure (Heart Failure) – Pipeline by Inserm Transfert SA, 2022

Congestive Heart Failure (Heart Failure) – Pipeline by Intra-Cellular Therapies Inc, 2022

Congestive Heart Failure (Heart Failure) – Pipeline by INVENT Pharmaceuticals Inc, 2022

Congestive Heart Failure (Heart Failure) – Pipeline by Ionis Pharmaceuticals Inc, 2022

Congestive Heart Failure (Heart Failure) – Pipeline by Japan Tobacco Inc, 2022

Congestive Heart Failure (Heart Failure) – Pipeline by Johnson & Johnson, 2022

Congestive Heart Failure (Heart Failure) – Pipeline by Katakura Industries Co Ltd, 2022

Congestive Heart Failure (Heart Failure) – Pipeline by KBP Biosciences Co Ltd, 2022

Congestive Heart Failure (Heart Failure) – Pipeline by Larix Bioscience LLC, 2022

Congestive Heart Failure (Heart Failure) – Pipeline by Lead Discovery Center GmbH, 2022

Congestive Heart Failure (Heart Failure) – Pipeline by Les Laboratoires Servier SAS, 2022

Congestive Heart Failure (Heart Failure) – Pipeline by Lexicon Pharmaceuticals Inc, 2022

Congestive Heart Failure (Heart Failure) – Pipeline by Madeleine Pharmaceuticals Inc, 2022

Congestive Heart Failure (Heart Failure) – Pipeline by Mesoblast Ltd, 2022

Congestive Heart Failure (Heart Failure) – Pipeline by Metcela Inc, 2022

Congestive Heart Failure (Heart Failure) – Pipeline by Mitsubishi Tanabe Pharma Corp, 2022

Congestive Heart Failure (Heart Failure) – Pipeline by Moderna Inc, 2022

Congestive Heart Failure (Heart Failure) – Pipeline by NanoCor Therapeutics Inc, 2022

Congestive Heart Failure (Heart Failure) – Pipeline by NeoProgen Inc, 2022

Congestive Heart Failure (Heart Failure) – Pipeline by Novartis AG, 2022

Congestive Heart Failure (Heart Failure) – Pipeline by Novelstar Pharmaceuticals Inc, 2022

Congestive Heart Failure (Heart Failure) – Pipeline by NovoMedix LLC, 2022

Congestive Heart Failure (Heart Failure) – Pipeline by Olatec Therapeutics LLC, 2022

Congestive Heart Failure (Heart Failure) – Pipeline by Organicell Regenerative Medicine Inc, 2022

Congestive Heart Failure (Heart Failure) – Pipeline by Orig3N Inc, 2022

Congestive Heart Failure (Heart Failure) – Pipeline by Orion Corp, 2022

Congestive Heart Failure (Heart Failure) – Pipeline by Orizuru Therapeutics Inc, 2022

Congestive Heart Failure (Heart Failure) – Pipeline by Otsuka Pharmaceutical Co Ltd, 2022

Congestive Heart Failure (Heart Failure) – Pipeline by Palatin Technologies Inc, 2022

Congestive Heart Failure (Heart Failure) – Pipeline by Paradigm Biopharmaceuticals Ltd, 2022

Congestive Heart Failure (Heart Failure) – Pipeline by Pfizer Inc, 2022

Congestive Heart Failure (Heart Failure) – Pipeline by Pharchoice Therapeutics Inc, 2022

Congestive Heart Failure (Heart Failure) – Pipeline by PhaseBio Pharmaceuticals Inc, 2022

Congestive Heart Failure (Heart Failure) – Pipeline by Phrixus Pharmaceuticals Inc, 2022

Congestive Heart Failure (Heart Failure) – Pipeline by Poxel SA, 2022

Congestive Heart Failure (Heart Failure) – Pipeline by Procella Therapeutics AB, 2022

Congestive Heart Failure (Heart Failure) – Pipeline by Prolifagen LLC, 2022

Congestive Heart Failure (Heart Failure) – Pipeline by Proveca Ltd, 2022

Congestive Heart Failure (Heart Failure) – Pipeline by Q BioMed Inc, 2022

Congestive Heart Failure (Heart Failure) – Pipeline by Qanatpharma GmbH, 2022

Congestive Heart Failure (Heart Failure) – Pipeline by Quantum Genomics SA, 2022

Congestive Heart Failure (Heart Failure) – Pipeline by Qurgen Inc, 2022

Congestive Heart Failure (Heart Failure) – Pipeline by Ramino-Bio Ltd, 2022

Congestive Heart Failure (Heart Failure) – Pipeline by Recardio Inc, 2022

Congestive Heart Failure (Heart Failure) – Pipeline by Regeneron Pharmaceuticals Inc, 2022

Congestive Heart Failure (Heart Failure) – Pipeline by Renova Therapeutics Inc, 2022

Congestive Heart Failure (Heart Failure) – Pipeline by Ribomic Inc, 2022

Congestive Heart Failure (Heart Failure) – Pipeline by Rivus Pharmaceuticals Inc, 2022

Congestive Heart Failure (Heart Failure) – Pipeline by Rnatives Ltd, 2022

Congestive Heart Failure (Heart Failure) – Pipeline by Rockwell Medical Inc, 2022

Congestive Heart Failure (Heart Failure) – Pipeline by Saillant Therapeutics BV, 2022

Congestive Heart Failure (Heart Failure) – Pipeline by Saje Pharma LLC, 2022

Congestive Heart Failure (Heart Failure) – Pipeline by Saliogen Therapeutics Inc, 2022

Congestive Heart Failure (Heart Failure) – Pipeline by Salubris Biotherapeutics Inc, 2022

Congestive Heart Failure (Heart Failure) – Pipeline by Sana Biotechnology Inc, 2022

Congestive Heart Failure (Heart Failure) – Pipeline by Sanofi, 2022

Congestive Heart Failure (Heart Failure) – Pipeline by Sarfez Pharmaceuticals Inc, 2022

Congestive Heart Failure (Heart Failure) – Pipeline by scPharmaceuticals Inc, 2022

Congestive Heart Failure (Heart Failure) – Pipeline by Senju Pharmaceutical Co Ltd, 2022

Congestive Heart Failure (Heart Failure) – Pipeline by Shandong Danhong Pharmaceutical Co Ltd, 2022

Congestive Heart Failure (Heart Failure) – Pipeline by Shanghai Hongyitang Biomedical Technology Co Ltd, 2022

Congestive Heart Failure (Heart Failure) – Pipeline by Shanghai Life Science & Technology, 2022

Congestive Heart Failure (Heart Failure) – Pipeline by Shenzhen Salubris Pharmaceuticals Co Ltd, 2022

Congestive Heart Failure (Heart Failure) – Pipeline by Shin Poong Pharm Co Ltd, 2022

Congestive Heart Failure (Heart Failure) – Pipeline by Signal Pharma Ltd, 2022

Congestive Heart Failure (Heart Failure) – Pipeline by Silver Creek Pharmaceuticals Inc, 2022

Congestive Heart Failure (Heart Failure) – Pipeline by siRNAgen Therapeutics Corp, 2022

Congestive Heart Failure (Heart Failure) – Pipeline by Sorrento Therapeutics Inc, 2022

Congestive Heart Failure (Heart Failure) – Pipeline by Stemedica Cell Technologies Inc, 2022

Congestive Heart Failure (Heart Failure) – Pipeline by Sumocor LLC, 2022

Congestive Heart Failure (Heart Failure) – Pipeline by Sun Pharma Advanced Research Company Ltd, 2022

Congestive Heart Failure (Heart Failure) – Pipeline by Suzhou Pharmavan Cancer Research Center Co Ltd, 2022

Congestive Heart Failure (Heart Failure) – Pipeline by T&R Biofab Co Ltd, 2022

Congestive Heart Failure (Heart Failure) – Pipeline by Takeda Pharmaceutical Co Ltd, 2022

Congestive Heart Failure (Heart Failure) – Pipeline by Techfields Pharma Co Ltd, 2022

Congestive Heart Failure (Heart Failure) – Pipeline by Tenaya Therapeutics Inc, 2022

Congestive Heart Failure (Heart Failure) – Pipeline by Titan Pharmaceuticals Inc, 2022

Congestive Heart Failure (Heart Failure) – Pipeline by Toa Eiyo Ltd, 2022

Congestive Heart Failure (Heart Failure) – Pipeline by Torrent Pharmaceuticals Ltd, 2022

Congestive Heart Failure (Heart Failure) – Pipeline by TransThera Sciences (Nanjing) Inc, 2022

Congestive Heart Failure (Heart Failure) – Pipeline by TreeFrog Therapeutics SAS, 2022

Congestive Heart Failure (Heart Failure) – Pipeline by Trio Medicines Ltd, 2022

Congestive Heart Failure (Heart Failure) – Pipeline by Triple-Gene LLC, 2022

Congestive Heart Failure (Heart Failure) – Pipeline by U.S. Stem Cell Inc, 2022

Congestive Heart Failure (Heart Failure) – Pipeline by Valo Health LLC, 2022

Congestive Heart Failure (Heart Failure) – Pipeline by Viatris Inc, 2022

Congestive Heart Failure (Heart Failure) – Pipeline by ViCardia Therapeutics Inc, 2022

Congestive Heart Failure (Heart Failure) – Pipeline by Viera BioScience Inc, 2022

Congestive Heart Failure (Heart Failure) – Pipeline by Vifor Pharma Ltd, 2022

Congestive Heart Failure (Heart Failure) – Pipeline by Viridian Therapeutics Inc, 2022

Congestive Heart Failure (Heart Failure) – Pipeline by Viscofan BioEngineering, 2022

Congestive Heart Failure (Heart Failure) – Pipeline by Windtree Therapeutics Inc, 2022

Congestive Heart Failure (Heart Failure) – Pipeline by Wuhan LL Science and Technology Development Co Ltd, 2022

Congestive Heart Failure (Heart Failure) – Pipeline by XyloCor Therapeutics Inc, 2022

Congestive Heart Failure (Heart Failure) – Pipeline by YAP Therapeutics Inc, 2022

Congestive Heart Failure (Heart Failure) – Pipeline by Zensun (Shanghai) Sci & Tech Co Ltd, 2022

Congestive Heart Failure (Heart Failure) – Dormant Projects, 2022

Congestive Heart Failure (Heart Failure) – Dormant Projects, 2022 (Contd..1)

Congestive Heart Failure (Heart Failure) – Dormant Projects, 2022 (Contd..2)

Congestive Heart Failure (Heart Failure) – Dormant Projects, 2022 (Contd..3)

Congestive Heart Failure (Heart Failure) – Dormant Projects, 2022 (Contd..4)

Congestive Heart Failure (Heart Failure) – Dormant Projects, 2022 (Contd..5)

Congestive Heart Failure (Heart Failure) – Dormant Projects, 2022 (Contd..6)

Congestive Heart Failure (Heart Failure) – Dormant Projects, 2022 (Contd..7)

Congestive Heart Failure (Heart Failure) – Dormant Projects, 2022 (Contd..8)

Congestive Heart Failure (Heart Failure) – Dormant Projects, 2022 (Contd..9)

Congestive Heart Failure (Heart Failure) – Dormant Projects, 2022 (Contd..10)

Congestive Heart Failure (Heart Failure) – Discontinued Products, 2022

Congestive Heart Failure (Heart Failure) – Discontinued Products, 2022 (Contd..1)

Figures

List of Figures

Number of Products under Development for Congestive Heart Failure (Heart Failure), 2022

Number of Products under Development by Companies, 2022

Number of Products under Development by Universities/Institutes, 2022

Number of Products by Targets, 2022

Number of Products by Stage and Top 10 Targets, 2022

Number of Products by Top 10 Mechanism of Actions, 2022

Number of Products by Stage and Top 10 Mechanism of Actions, 2022

Number of Products by Routes of Administration, 2022

Number of Products by Stage and Routes of Administration, 2022

Number of Products by Top 10 Molecule Types, 2022

Number of Products by Stage and Top 10 Molecule Types, 2022

Frequently asked questions

Congestive Heart Failure (Heart Failure) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update thematic reports
Currency USD
$2,500

Can be used by individual purchaser only

$7,500

Can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company


Undecided about purchasing this report?

Enquire Before Buying

Get in touch to find out about multi-purchase discounts

reportstore@globaldata.com
Tel +44 20 7947 2745

Every customer’s requirement is unique. With over 220,000 construction projects tracked, we can create a tailored dataset for you based on the types of projects you are looking for. Please get in touch with your specific requirements and we can send you a quote.

See what our customers are saying

“The GlobalData platform is our go-to tool for intelligence services. GlobalData provides an easy way to access comprehensive intelligence data around multiple sectors, which essentially makes it a one-for-all intelligence platform, for tendering and approaching customers.

GlobalData is very customer orientated, with a high degree of personalised services, which benefits everyday use. The highly detailed project intelligence and forecast reports can be utilised across multiple departments and workflow scopes, from operational to strategic level, and often support strategic decisions. GlobalData Analytics and visualisation solutions has contributed positively when preparing management presentations and strategic papers.”

Business Intelligence & Marketing Manager, SAL Heavy Lift

“COVID-19 has caused significant interference to our business and the COVID-19 intelligence from GlobalData has helped us reach better decisions around strategy. These two highlights have helped enormously to understand the projections into the future concerning our business units, we also utilise the project database to source new projects for Liebherr-Werk to use as an additional source to pitch for new business.”

Market Analyst & Management, Liebherr-Werk

Your daily news has saved me a lot of time and keeps me up-to-date with what is happening in the market, I like that you almost always have a link to the source origin. We also use your market data in our Strategic Business Process to support our business decisions. By having everything in one place on the Intelligence Center it has saved me a lot of time versus looking on different sources, the alert function also helps with this.

Head of Key Accounts, Saab AB

Having used several other market research companies, I find that GlobalData manages to provide that ‘difficult-to-get’ market data that others can’t, as well as very diverse and complete consumer surveys.

Marketing Intelligence Manager, Portugal Foods

Our experience with GlobalData has been very good, from the platform itself to the people. I find that the analysts and the account team have a high level of customer focus and responsiveness and therefore I can always rely on. The platform is more holistic than other providers. It is convenient and almost like a one stop shop. The pricing suite is highly competitive and value for our organisation.

I like reports that inform new segments such as the analysis on generation Z, millennials, the impact of COVID 19 to our banking customers and their new channel habits. Secondly the specialist insight on affluent sector significantly increases our understanding about this group of customers. The combination of those give us depth and breadth of the evolving market.

I’m in the business of answering and helping people make decisions so with the intelligence center I can do that, effectively and efficiently. I can share quickly key insights that answer and satisfy our country stakeholders by giving them many quality studies and primary research about competitive landscape beyond the outlook of our bank. It helps me be seen as an advisory partner and that makes a big difference. A big benefit of our subscription is that no one holds the whole data and because it allows so many people, so many different parts of our organisation have access, it enables all teams to have the same level of knowledge and decision support.

Head of Customer Insight and Research, Standard Chartered

“I know that I can always rely on Globaldata’s work when I’m searching for the right consumer and market insights. I use Globaldata insights to understand the changing market & consumer landscape and help create better taste & wellbeing solutions for our customers in food, beverage and healthcare industries.

Globaldata has the right data and the reports are of very high quality compared to your competitors. Globaldata not only has overall market sizes & consumer insights on food & beverages but also provides insights at the ingredient & flavour level. That is key for B2B companies like Givaudan. This way we understand our customers’ business and also gain insight to our unique industry”

Head of Consumer Sensory Insights, Givaudan

GlobalData provides a great range of information and reports on various sectors that is highly relevant, timely, easy to access and utilise.  The reports and data dashboards help engagement with clients; they provide valuable industry and market insights that can enrich client conversations and can help in the shaping of value propositions. Moreover, using GlobalData products has helped increase my knowledge of the finance sector, the players within it, and the general threats and opportunities.

I find the consumer surveys that are carried out to be extremely beneficial and not something I have seen anywhere else. They provided an insightful view of why and which consumers take (or don’t) particular financial products. This can help shape conversations with clients to ensure they make the right strategic decisions for their business.

One of the challenges I have found is that data in the payments space is often piecemeal. With GD all of the data I need is in one place, but it also comes with additional market reports that provide useful extra context and information. Having the ability to set-up alerts on relevant movements in the industry, be it competitors or customers, and have them emailed directly to me, ensures I get early sight of industry activity and don’t have to search for news.

Senior Account Manager, TSYS
Go even deeper with GlobalData Intelligence Center

Every Company Report we produce is powered by the GlobalData Intelligence Center.

Subscribing to our intelligence platform means you can monitor developments at Congestive Heart Failure (Heart Failure) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update in real time.

  • Access a live Congestive Heart Failure (Heart Failure) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update dashboard for 12 months, with up-to-the-minute insights.
  • Fuel your decision making with real-time deal coverage and media activity.
  • Turn insights on financials, deals, products and pipelines into powerful agents of commercial advantage.